November 8, 2021
Revolution Medicines to Participate in Stifel 2021 Virtual Healthcare Conference
November 3, 2021
Revolution Medicines to Report Financial Results for Third Quarter 2021 After Market Close on November 10, 2021
September 30, 2021
Revolution Medicines to Present New Preclinical Data from RAS(ON) Inhibitor Programs at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
September 15, 2021
Revolution Medicines to Participate in 3rd Annual RAS-Targeted Drug Development Summit
September 7, 2021
Revolution Medicines to Present at H.C. Wainwright 23rd Annual Global Investment Conference
August 11, 2021
Revolution Medicines Reports Second Quarter Financial Results and Update on Corporate Progress
August 4, 2021
Revolution Medicines to Report Financial Results for Second Quarter 2021 After Market Close on August 11, 2021
June 24, 2021
Revolution Medicines Announces Publication of Scientific Paper Describing Novel Class of Anti-Tumor Compounds Targeting mTORC1
June 10, 2021
Revolution Medicines to Host Science Talk Webcast Highlighting Learnings from Recent Preclinical and Clinical Studies of RAS Inhibitors
June 2, 2021
Revolution Medicines to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference